脐带血干细胞治疗失代偿期原发性胆汁性肝硬化疗效观察

doi:10.3969/j.issn.1672-5069.2016.02.026

Abstract

Zhou Xinren, Wang Fang, Yun Shenghao. Intrahepatic transplantation of umbilical cord blood stem cells in treatment of patients with decompensated primary biliary cirrhosis[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(2): 219-220.

References

[1] Aijo T,Edelman SM,Lonnberg T,et al. An integrative computational systems biology approach identifies differentially regulated dynamic transcriptome signatures which drive the initiation of human T helper cell differentiation. Bmc Genomics,2012,13:572.
[2] Cahill AG,Roehl KA,Odibo AO,et al. Association of atypical decelerations with acidemia. Obstet Gynecol,2012,120（6）:1387-1393.
[3] 王方,张静,周新人,等. 经门静脉自体骨髓干细胞移植治疗失代偿期肝硬化18 例疗效观察.实用肝脏病杂志,2011,14（3）：200-201.
[4] Terai S,Ishikawa T,Omori K,et al. Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy. Stem Cells,2006,24（10）: 2292-2298.
[5] 王方,寇俊峰,云升皓,等. 两种途径移植自体骨髓干细胞治疗肝硬化患者疗效比较.临床肝胆病杂志,2013,29（11）:844-847.
[6] Khan AA,Parveen N,Mahaboob VS,et al. Safety and efficacy of autologous bone marrow stem cell transplantation through hepatic artery for the treatment of chronic liver failure: a preliminary study. Transplant Proc,2008,40（4）:1140-1144.
[7] 高远征,贾素华,刘玉英,等. 异基因脐血干细胞移植治疗失代偿期肝硬化的疗效观察. 临床肝胆病杂志,2010,26（6）：613-617.
[8] 陈海鸥,胡小宜,刘洪娟,等. 脐血干细胞移植治疗肝硬化的疗效观察.肝脏,2010,15（2）：81-83.
[9] 杨华强,王云甫,杜玲,等. 脐血干细胞移植治疗失代偿期肝硬化的临床疗效. 现代生物医学进展,2010,10（23）：4497-4499.
[10] 范娅涵,蒋天伦,黎儒青,等. 治疗用脐血干细胞的制备与初步临床应用. 中国输血杂志,2010,23（3）：179-182.
[11] 王方,张静,枫淑贤,等.经肝动脉注入脐带血干细胞治疗失代偿期肝硬化患者25 例疗效观察.实用肝脏病杂志,2012,15（6）：535-537.
[12] 周汉超,刘黎,周健,等. 骨髓、脐血干细胞中淋巴细胞和单核细胞与CD34、CD38 亚型细胞百分比在治疗肝硬化中的比较. 中华临床医师杂志（电子版）,2011,5（6）：1731-1733.
[13] Nikeghbalian S,Pournasr B,Aghdami N,et al. Autologous transplantationof bone ma
Iran med, 2011,14（1）:12-17.

[1]	Gao Lei, Cao Lei, Wang Ruifang, et al.. Protective effect of human umbilical cord mesenchymal stem cell transplantation on alcoholic liver injury in rats [J]. Journal of Practical Hepatology, 2019, 22(6): 812-815.
[2]	Chen Meimei, Duan Xiaoyan, Cao Haixia, et al.. Improvement of clinical symptoms and serum hepatic fibrosis markers in patients with primary biliary cirrhosis by compound Biejiaruangan tablets [J]. Journal of Practical Hepatology, 2019, 22(6): 880-883.
[3]	Zhao Fangfang, Zhai Yongzhen, Feng Guohe. Efficacy and safety of autologous peripheral blood stem cell transplantation in patients with hepatitis B cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(5): 700-703.
[4]	Lu Ximei, Kang Yanfei, Song Zhiyong, et al. Application of color Doppler ultrasonography in the diagnosis of biliary complications in patients after liver transplantation [J]. Journal of Practical Hepatology, 2019, 22(4): 589-592.
[5]	Wang Chan, Qin Wei, Dai Yong, et al.. Clinical efficacy of autologous peripheral blood stem cell transplantation in patients with hepatitis B cirrhosis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 97-100.
[6]	Liu Yingchuan, Zhao Pengcheng, You Ting, et al.. Changes of peripheral blood 25-（OH） 2-D3 levels and peripheral T lymphocyte subsets in patients with primary biliary cirrhosis receiving vitamin D supplementation and ursodeoxycholic acid treatment [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(6): 907-910.
[7]	Ding Lei, Zhang Zhen, Liu Fuquan.. Clinical application of real-time ultrasound elastography in the evaluation of ischemic biliary lesions in patients with orthotopic liver transplantation [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(6): 963-966.
[8]	Zhang Junfei, Song Haiyan, Chen Xi, et al.. Clinical observation of intrahepatic human umbilical cord mesenchymal stem cell transplantation in the treatment of patients with hepatitis B-induced decompensated liver cirrhosis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(5): 693-696.
[9]	Sun Jianjun, Wang Weiwei, Chen Guoyong, et al.. Effect of Xueshuantong on hepatic arterial blood flow and resistance index in patients after orthotopic liver transplantation [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(5): 769-772.
[10]	Liu Jinguo, Wang Baokui. Efficacy of Fufangbiejia Ruanganpian and ursodeoxycholic acid combination in the treatment of patients with primary biliary cirrhosis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(3): 340-343.
[11]	Zhao Yu, Zhu Yu, Zhang Daizhong. Efficacy of intrahepatic transplantation of human umbilical cord mesenchymal stem cells combined with matrine in the treatment of patients with decompensated hepatitis B cirrhosis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(3): 360-363.
[12]	Chen Hui, Ren Wanlei, Yang Aiting. Hepatic progenitor cell transplantation accelerates spontaneous reverse of hepatic fibrosis in rats with carbon tetrachloride-induced liver fibrosis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(3): 376-379.
[13]	Qin Wei, Chen Yuping, Yang Zhao, et al. Expression of transforming growth factor β-1 in liver tissues of patients with primary biliary cirrhosis and its relationship with liver fibrosis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(2): 237-240.
[14]	Chen Xiaojun, Song Yang. Changes of peripheral blood T lymphocyte subsets and efficacy of ursodesoxycholic acid and vitamin D combination in treatment of patients with primary biliary cholangitis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(1): 80-83.
[15]	Yang Ruixu, Zhou Da, Fan Jiangao. Microbiome-based metabolite in the treatment of patients with non-alcoholic fatty liver diseases [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(6): 643-646.

Intrahepatic transplantation of umbilical cord blood stem cells in treatment of patients with decompensated primary biliary cirrhosis

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments